Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Kamada Ltd.    KMDA   IL0010941198

KAMADA LTD.

(KMDA)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
09/12/2019 09/15/2019 09/16/2019 09/18/2019 09/19/2019 Date
1873(c) 1871(c) 1852(c) 1828(c) 1819(c) Last
30 320 10 788 19 935 60 930 28 772 Volume
+1.41% -0.11% -1.02% -1.30% -0.49% Change
More quotes
Financials (ILS)
Sales 2019 449 M
EBIT 2019 77,7 M
Net income 2019 70,5 M
Debt 2019 -
Yield 2019 -
Sales 2020 480 M
EBIT 2020 83,6 M
Net income 2020 67,5 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 -
Capi. / Sales2019 1,64x
Capi. / Sales2020 1,53x
Capitalization 736 M
More Financials
Company
Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology. It offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on KAMADA LTD.
09/03Kamada Announces Extension of GLASSIA® [Alpha1-Proteinase Inhibitor (Human)] ..
GL
08/08Kamada Reports Discussions with Takeda Regarding a Potential Extension of the..
GL
08/06KAMADA : 2Q Earnings Snapshot
AQ
08/06Kamada Reports Financial Results for Second Quarter and First Six Months of 2..
GL
07/31KAMADA : to Report Second Quarter 2019 Financial Results and Host Conference Cal..
AQ
05/14KAMADA : 1Q Earnings Snapshot
AQ
05/14KAMADA : Reports Financial Results for First Quarter of 2019
AQ
05/07KAMADA : to Report First Quarter 2019 Financial Results and Host Conference Call..
AQ
04/16KAMADA : announces FDA acceptance of Inhaled AAT program path forward
AQ
More news
Sector news : Biopharmaceuticals
09/20DR REDDY LABORATORIES : . Reddy's Suspends Shipments of Ranitidine
DJ
09/20ALLERGAN : Form 8.3 -
DJ
09/20NOVO NORDISK : FDA Approves Novo Nordisk's Rybelsus Diabetes Tablets
DJ
09/20ZOETIS : Says EC Grants Marketing Authorization for Antiparasitic Medication for..
DJ
09/20MERCK : Pfizer Get CHMP Positive Opinion for Bavencio
DJ
More sector news : Biopharmaceuticals
Chart KAMADA LTD.
Duration : Period :
Kamada Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KAMADA LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 18,19  ILS
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Amir London Chief Executive Officer
Leon Y. Recanati Chairman
Eran Nir Vice President-Operations
Chaime Orlev Chief Financial Officer
Liliana Bar Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
KAMADA LTD.-2.68%209
CSL LIMITED26.93%72 507
BIOGEN INC.-20.65%43 459
ALEXION PHARMACEUTICALS8.54%23 694
SAMSUNG BIOLOGICS CO LTD--.--%18 246
GRIFOLS15.63%18 022